2 drug(s) with this reaction
826 total reports
Maternal Exposure During Pregnancy has been reported as an adverse reaction across 2 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 826 adverse event reports mention maternal exposure during pregnancy in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with maternal exposure during pregnancy, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have maternal exposure during pregnancy listed in their FDA adverse event reports, sorted by report count:
In addition to maternal exposure during pregnancy, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
2 drug(s) manufactured by Chattem Inc have maternal exposure during pregnancy listed in their FDA adverse event reports: TRIAMCINOLONE ACETONIDE, DOXYLAMINE SUCCINATE.
There are a combined 826 reports of maternal exposure during pregnancy across 2 Chattem Inc drug(s) in the FDA adverse event database.